Feature Healthcare Stocks From $1 to $8? Why Analyst Experts Are Bullish on Cardiol Sometimes stock market performance doesn’t line up with the fundamentals of a… Robin LeffertsApril 1, 2025
Healthcare Stocks Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug… Ryan AllwayFebruary 20, 2025
Feature Healthcare Stocks These Healthcare Stocks Significantly Outperformed the Industry in 2024 While the stock market broadly experienced significant gains in 2024, a few… Robin LeffertsJanuary 27, 2025
Feature Healthcare Stocks Top News Positive Phase 2 Results Signal Promising Future For Cardiol Therapeutics The future of smaller drug development companies frequently hinges on the results… Robin LeffertsJune 20, 2024
Healthcare Stocks Top News Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis Administration of CardiolRx™ led to a marked reduction in the primary efficacy… Ryan AllwayJune 13, 2024
Feature Healthcare Stocks Top News Near-Term Catalysts on the Horizon for Cardiol Therapeutics Investing in smaller drug development companies requires patience. The journey from discovery… Robin LeffertsMay 28, 2024
Feature Healthcare Stocks Top News Analyst and Research Coverage Bullish on Cardiol Therapeutics Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) has in some ways burst… Robin LeffertsMay 1, 2024
Feature Healthcare Stocks Top News The Impact of Positive Phase 2 Trial Results on a Smaller Company A few weeks back, we covered the effect an Orphan Drug Designation… Robin LeffertsMarch 12, 2024
Feature Healthcare Stocks Top News The Impact of Orphan Drug Development on a Smaller Company Orphan drugs treat conditions with less than 200,000 patients annually in the… Robin LeffertsFebruary 6, 2024
Feature Healthcare Stocks Top News Distinguished Health Centers and Experts Lead Recurrent Pericarditis, Acute Myocarditis Clinical Trials Any clinical trial program relies heavily on its administrators, advisors, and designers.… Robin LeffertsJanuary 16, 2024
